{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:46:07Z","timestamp":1780519567777,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.biopha.2016.07.004","type":"journal-article","created":{"date-parts":[[2016,7,17]],"date-time":"2016-07-17T13:45:11Z","timestamp":1468763111000},"page":"456-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer"],"prefix":"10.1016","volume":"83","author":[{"given":"Elaheh","family":"Nooshinfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Bashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Safaroghli-Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Bayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Rezaei-Tavirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed H.","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Esmaeil","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2016.07.004_bib0005","doi-asserted-by":"crossref","first-page":"798","DOI":"10.5812\/ircmj.3631","article-title":"Survival rate of breast cancer based on geographical variation in Iran: a national study","volume":"14","author":"Movahedi","year":"2012","journal-title":"Iran. Red Crescent Med. J."},{"issue":"4","key":"10.1016\/j.biopha.2016.07.004_bib0010","first-page":"154","article-title":"A novel scheme for optimal control of a nonlinear delay differential equations model to determine effective and optimal administrating chemotherapy agents in breast cancer","volume":"4","author":"Ramezanpour","year":"2011","journal-title":"Iran. J. Cancer Prev."},{"issue":"21","key":"10.1016\/j.biopha.2016.07.004_bib0015","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM199605233342102","article-title":"The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer","volume":"334","author":"Recht","year":"1996","journal-title":"New Engl. J. Med."},{"issue":"12","key":"10.1016\/j.biopha.2016.07.004_bib0020","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1080\/10428190412331272686","article-title":"Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside","volume":"45","author":"Rojewski","year":"2004","journal-title":"Leukemia Lymphoma"},{"issue":"7","key":"10.1016\/j.biopha.2016.07.004_bib0025","first-page":"583","article-title":"Arsenic trioxide induces the apoptosis of prostate cancer PC-3 cells via the P38 signaling pathway","volume":"19","author":"Su","year":"2013","journal-title":"Zhonghua nan ke xue:\u2009Natl. J. Androl."},{"issue":"3","key":"10.1016\/j.biopha.2016.07.004_bib0030","first-page":"1067","article-title":"Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity","volume":"46","author":"Zheng","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"35","key":"10.1016\/j.biopha.2016.07.004_bib0035","doi-asserted-by":"crossref","first-page":"37300","DOI":"10.18632\/oncotarget.5836","article-title":"Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth","volume":"6","author":"Zhou","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2016.07.004_bib0040","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3892\/mmr.2015.3558","article-title":"Arsenic trioxide inhibits breast cancer cell growth via microRNA-328\/hERG pathway in MCF-7 cells","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2016.07.004_bib0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF02787360","article-title":"Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases","volume":"16","author":"Huang","year":"1999","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2016.07.004_bib0050","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood.V94.6.2102","article-title":"Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway","volume":"94","author":"Jing","year":"1999","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.biopha.2016.07.004_bib0055","first-page":"776","article-title":"Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells","volume":"59","author":"Li","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2016.07.004_bib0060","article-title":"Arsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunction","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2016.07.004_bib0065","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.toxlet.2014.11.028","article-title":"Arsenic trioxide suppresses transcription of hTERT through down-regulation of multiple transcription factors in HL-60 leukemia cells","volume":"232","author":"Zhang","year":"2015","journal-title":"Toxicol. Lett."},{"issue":"11","key":"10.1016\/j.biopha.2016.07.004_bib0070","doi-asserted-by":"crossref","first-page":"e113199","DOI":"10.1371\/journal.pone.0113199","article-title":"Downregulation of hTERT: an important As 2 O 3 induced mechanism of apoptosis in myelodysplastic syndrome","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.07.004_bib0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.pharmtox.48.113006.094626","article-title":"Circadian timing in cancer treatments","volume":"50","author":"L\u00e9vi","year":"2010","journal-title":"Annu. Rev. Pharmacool. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2016.07.004_bib0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40520-013-0118-6","article-title":"Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks","volume":"25","author":"Rondanelli","year":"2013","journal-title":"Aging Clin. Exp. Res."},{"issue":"15","key":"10.1016\/j.biopha.2016.07.004_bib0085","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1158\/0008-5472.CAN-13-3156","article-title":"Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer","volume":"74","author":"Dauchy","year":"2014","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2016.07.004_bib0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-079X.2008.00645.x","article-title":"Evidence for a biphasic apoptotic pathway induced by melatonin in MCF\u20107 breast cancer cells","volume":"46","author":"Cucina","year":"2009","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.biopha.2016.07.004_bib0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pros.20155","article-title":"Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism","volume":"63","author":"Sainz","year":"2005","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.biopha.2016.07.004_bib0100","first-page":"197","article-title":"Protective and sensitive effects of melatonin combined with adriamycin on ER+ (estrogen receptor) breast cancer","volume":"36","author":"Ma","year":"2014","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2016.07.004_bib0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/iep.12094","article-title":"Melatonin potentiates the anti\u2010tumour effect of pravastatin in rat mammary gland carcinoma model","volume":"95","author":"Orend\u00e1\u0161","year":"2014","journal-title":"Int. J. Exp. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2016.07.004_bib0110","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/bjc.1995.164","article-title":"Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone","volume":"71","author":"Lissoni","year":"1995","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2016.07.004_bib0115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00008469-199512000-00009","article-title":"Chemoprevention by melatonin and combined melatonin-tamoxifen therapy of second generation nitroso-methylurea-induced mammary tumours in rats","volume":"4","author":"Kothari","year":"1995","journal-title":"Eur. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.biopha.2016.07.004_bib0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jcb.20102","article-title":"Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells","volume":"93","author":"Chow","year":"2004","journal-title":"J. Cell. Biochem."},{"issue":"23","key":"10.1016\/j.biopha.2016.07.004_bib0125","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1158\/1078-0432.CCR-04-1087","article-title":"Evaluation of combination chemotherapy integration of nonlinear regression: curve shift, isobologram, and combination index analyses","volume":"10","author":"Zhao","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2016.07.004_bib0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mce.2015.11.016","article-title":"Melatonin enhances arsenic trioxide-induced cell death via sustained upregulation of Redd1 expression in breast cancer cells","volume":"422","author":"Yun","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2016.07.004_bib0135","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/jpi.12117","article-title":"Molecular deficiency (ies) in MT1 melatonin signaling pathway underlies the melatonin\u2010unresponsive phenotype in MDA\u2010MB\u2010231 human breast cancer cells","volume":"56","author":"Mao","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2016.07.004_bib0140","first-page":"1","article-title":"Melatonin, an inhibitory agent in breast cancer","author":"Nooshinfar","year":"2016","journal-title":"Breast Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2016.07.004_bib0145","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.3390\/ijms13089627","article-title":"Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer","volume":"13","author":"Xia","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2016.07.004_bib0150","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mce.2013.07.002","article-title":"Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis","volume":"377","author":"Zekri","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2016.07.004_bib0155","first-page":"1239","article-title":"Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription","volume":"6","author":"Kanaya","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.biopha.2016.07.004_bib0160","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/sj.onc.1208232","article-title":"hTERT antagonizes p53-induced apoptosis independently of telomerase activity","volume":"24","author":"Rahman","year":"2005","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biopha.2016.07.004_bib0165","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ccr.2009.03.021","article-title":"Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis","volume":"15","author":"Grinkevich","year":"2009","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.biopha.2016.07.004_bib0170","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.yexcr.2004.12.014","article-title":"Survivin enhances telomerase activity via up-regulation of specificity protein 1-and c-Myc-mediated human telomerase reverse transcriptase gene transcription","volume":"305","author":"Endoh","year":"2005","journal-title":"Exp. Cell Res."},{"issue":"12","key":"10.1016\/j.biopha.2016.07.004_bib0175","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1200\/JCO.2002.09.002","article-title":"Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results","volume":"20","author":"O\u2019shaughnessy","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2016.07.004_bib0180","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2174\/156800908786733469","article-title":"Melatonin as a selective estrogen enzyme modulator","volume":"8","author":"Cos","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.biopha.2016.07.004_bib0185","series-title":"Melatonin: From Molecules to Therapy","first-page":"3","article-title":"Melatonin: an endogenous antiestrogen with oncostatic properties","author":"S\u00e1nchez-Barcel\u00f3","year":"2007"},{"issue":"3","key":"10.1016\/j.biopha.2016.07.004_bib0190","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pneurobio.2008.04.001","article-title":"Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways","volume":"85","author":"Pandi-Perumal","year":"2008","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.biopha.2016.07.004_bib0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/frne.1999.0194","article-title":"Melatonin and mammary pathological growth","volume":"21","author":"Cos","year":"2000","journal-title":"Front. Neuroendocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2016.07.004_bib0200","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ijc.10827","article-title":"The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER\u20102\/neu transgenic mice","volume":"103","author":"Anisimov","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2016.07.004_bib0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-079X.2006.00342.x","article-title":"Melatonin induces apoptosis in human neuroblastoma cancer cells","volume":"41","author":"Garc\u00eda\u2010Santos","year":"2006","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2016.07.004_bib0210","first-page":"1","article-title":"Synergic effects of doxorubicin and melatonin on apoptosis and mitochondrial oxidative stress in MCF-7 Breast cancer cells: involvement of TRPV1 channels","volume":"2015","author":"Ko\u015far","year":"2016","journal-title":"J. Membr. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2016.07.004_bib0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/jpi.12288","article-title":"Melatonin sensitizes human cervical cancer HeLa cells to cisplatin\u2010induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation","volume":"60","author":"Pariente","year":"2016","journal-title":"J. Pineal Res."},{"issue":"4","key":"10.1016\/j.biopha.2016.07.004_bib0220","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1600-079X.2010.00852.x","article-title":"Melatonin promotes puromycin\u2010induced apoptosis with activation of caspase\u20103 and 5\u2032\u2010adenosine monophosphate\u2010activated kinase\u2010alpha in human leukemia HL\u201060 cells","volume":"50","author":"Koh","year":"2011","journal-title":"J. Pineal Res."},{"issue":"4","key":"10.1016\/j.biopha.2016.07.004_bib0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-079X.2004.00207.x","article-title":"Melatonin\u2013estrogen interactions in breast cancer","volume":"38","author":"S\u00e1nchez\u2010Barcel\u00f3","year":"2005","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.biopha.2016.07.004_bib0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1383-5742(00)00035-1","article-title":"Regulation of p53 stability and activity in response to genotoxic stress","volume":"462","author":"Colman","year":"2000","journal-title":"Mutat. Res."},{"issue":"8","key":"10.1016\/j.biopha.2016.07.004_bib0235","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1101\/gad.9.8.935","article-title":"p53-dependent and independent expression of p21 during cell growth: differentiation, and DNA damage","volume":"9","author":"Macleod","year":"1995","journal-title":"Genes. Dev."},{"issue":"9","key":"10.1016\/j.biopha.2016.07.004_bib0240","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl2 family: regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2016.07.004_bib0245","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1349-7006.2000.tb00906.x","article-title":"Survivin as a radioresistance factor in pancreatic cancer","volume":"91","author":"Asanuma","year":"2000","journal-title":"Jpn. J. Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2016.07.004_bib0250","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ceb.2006.08.015","article-title":"The case for survivin as a regulator of microtubule dynamics and cell-death decisions","volume":"18","author":"Altieri","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2016.07.004_bib0255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1383-5742(99)00091-5","article-title":"Telomeres: telomerase, and myc: an update","volume":"462","author":"Cerni","year":"2000","journal-title":"Mutat. Res."},{"issue":"7","key":"10.1016\/j.biopha.2016.07.004_bib0260","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2174\/18715206113139990126","article-title":"BIBR 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for APL","volume":"13","author":"Bashash","year":"2013","journal-title":"Anticancer Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2016.07.004_bib0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/07357907.2011.629378","article-title":"Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription","volume":"30","author":"Bashash","year":"2012","journal-title":"Cancer Invest."},{"issue":"3","key":"10.1016\/j.biopha.2016.07.004_bib0270","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/10428194.2012.704034","article-title":"Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells","volume":"54","author":"Bashash","year":"2013","journal-title":"Leukemia Lymphoma"},{"issue":"19","key":"10.1016\/j.biopha.2016.07.004_bib0275","first-page":"5376","article-title":"Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway","volume":"60","author":"Wang","year":"2000","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2016.07.004_bib0280","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/1097-0347(200007)22:4<347::AID-HED6>3.0.CO;2-J","article-title":"Telomerase activity in head and neck tumors after introduction of wild-type p53: p21, p16, and E2F-1 genes by means of recombinant adenovirus","volume":"22","author":"Henderson","year":"2000","journal-title":"Head Neck"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216307119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216307119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:51:19Z","timestamp":1776945079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216307119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":56,"alternative-id":["S0753332216307119"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.07.004","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}